IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 29.659

Change

-0.09 (-0.29)%

Market Cap

USD 0.20B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

+0.13 (+0.68%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.43 (-0.77%)

USD 32.43B
DTB DTB

+0.15 (+0.77%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

-0.08 (-0.26%)

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC)

-1.87 (-3.56%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

-0.21 (-0.42%)

USD 22.73B
SGOV iShares® 0-3 Month Treasury B..

-0.39 (-0.39%)

USD 19.79B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.72 (-1.38%)

USD 11.73B
AVUV Avantis® U.S. Small Cap Value..

+0.01 (+0.01%)

USD 10.49B
DFUV Dimensional US Marketwide Valu..

-0.22 (-0.56%)

USD 10.15B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.51% 34% F 43% F
Dividend Return 0.32% 24% F 17% F
Total Return -1.19% 29% F 38% F
Trailing 12 Months  
Capital Gain 10.97% 65% D 66% D+
Dividend Return 0.88% 13% F 10% F
Total Return 11.86% 63% D 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.66% 69% C- 52% F
Dividend Return 2.85% 64% D 42% F
Total Return 0.19% 13% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 6.24% 69% C- 90% A-
Risk Adjusted Return 45.72% 71% C- 71% C-
Market Capitalization 0.20B 74% C 32% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.